SOAP Note for Gynecologic Health Assessment
Subjective: Ms. K is a 28-year-old female who presented to the clinic with a complaint of irregular vaginal bleeding for the past 3 months. She reported that her menstrual cycle had always been regular, lasting about 5 days with moderate flow. She denied any recent changes in her sexual activity or contraception use. Ms. K also reported occasional abdominal cramping and mild dyspareunia. Her past medical history was unremarkable, and she had no known allergies.
Check before you submit. Get Turnitin Score Report in 15 Minutes.
Don't risk the 'Red' score. Get the exact same Turnitin report your professor uses. Join 50,000+ students who submitted their essays with confidence this semester.
Objective: During the physical examination, vital signs were within normal limits, and abdominal examination was benign. A speculum examination revealed a healthy cervix with no visible lesions or discharge. There was no cervical motion tenderness or adnexal masses palpated on bimanual examination. A transvaginal ultrasound was performed, and the results showed an endometrial thickness of 10 mm.
Assessment: The differential diagnoses for Ms. K’s irregular vaginal bleeding include:
- Hormonal imbalance
- Polyps or fibroids in the uterus
- Endometrial hyperplasia or cancer
The primary diagnosis was endometrial hyperplasia, given the thickened endometrial lining seen on the ultrasound. The hormonal imbalance was considered a secondary diagnosis, as it could be a contributing factor to the endometrial hyperplasia.
Plan: Further diagnostic workup includes endometrial biopsy to rule out cancer and confirm the diagnosis of endometrial hyperplasia. Treatment and management include the use of progestin therapy to thin the endometrial lining and regularize menstrual cycles. Ms. K was also advised to discontinue the use of nonsteroidal anti-inflammatory drugs (NSAIDs) as they could worsen her symptoms.
Follow-up parameters include scheduling a follow-up appointment in 3 months to assess the effectiveness of the treatment plan and monitor for any adverse effects. If the endometrial biopsy confirms the diagnosis of endometrial hyperplasia without atypia, progestin therapy will be continued for 3-6 months, followed by repeat endometrial biopsy. If the biopsy shows atypical hyperplasia or cancer, the management plan will be modified accordingly.
Reflection notes: In a similar patient evaluation, I would obtain a more detailed menstrual history, including the onset, duration, and timing of the irregular bleeding, as well as any associated symptoms. I would also consider obtaining a complete blood count (CBC) and coagulation profile to rule out bleeding disorders. Additionally, I would ensure to provide clear and concise patient education regarding the importance of follow-up appointments and the management plan.
